ANALYSIS: It’s likely NZGCP’s Elevate fund-of-funds will miss out on a second vintage in this week’s Budget 2024. How will that affect VCs struggling to raise new funds?
ANALYSIS: Despite spending $24b on health this year, sector still under severe strain.
Under duress the supermarket duopoly is transforming – but aims to retain its invisible hand.
Francis Fukuyama argues the case against enemies on left and right.
ANALYSIS: NZ Funds talk up spring around the corner, despite crypto market’s carnage.
ANALYSIS: Fletcher Building is taking the heat for stockouts but it's a creature of a special environment.
ANALYSIS: The Government is rushing through legislation on political finance for no apparent reason.
ANALYSIS: Rocket Lab's share price has crashed since listing, but there are reasons for optimism.
Epidemiologist argues the case for better handling of toxic chemicals.
ANALYSIS: Why the FMA made Simplicity sit on the naughty step.